Appointment of Independent Director

Briscoe Group Limited (NZX/ASX code: BGP) The Board of Directors of Briscoe Group Limited advises that it has appointed Mark Callaghan as an Independent Non-Executive Director of Briscoe Group, to be effective from 1 January 2021. Mr Callaghan's appointment follows the announcement in March 2019 of the resignation from the Board of Mary Devine, and subsequent discussions with a number of potential candidates to fill the vacancy. Chairman, Dame Rosanne Meo said, "The search for an additional director has taken longer than we had anticipated due to the unprecedented challenges encountered as a result of Covid-19. "We are delighted that Mark will be joining the Board and believe his experience and skills will be of immense benefit to the Group. "A key feature of good governance is for Boards to consistently challenge themselves to ensure the highest level of service to the companies they serve. With Mark's appointment I am confident that the Briscoe Group Board of Directors will have an excellent balance of the attributes required to meet the future needs of the business." Mark Callaghan is an experienced business leader with demonstrated commercial abilities in strategy and operations gained across a number of notable FMCG organisations including Frucor Beverages and Cadbury Schweppes. He has held a variety of positions from marketing to CEO to Board Director. Mark is currently Chief Executive Officer of Phytomed Medicinal Herbs Ltd, the Independent Non-Executive Chairman of Office Products Depot Ltd and a member of the New Zealand Institute of Directors. In accordance with normal practice and the NZX Listing Rules, Mr Callaghan will retire as a Director of Briscoe Group at the 2021 Annual Meeting but intends to seek re-election by shareholders at that time. 16 December 2020 Dame Rosanne Meo Chairman End CA:00365160 For:BGP Type:ADMIN Time:2020-12-16 14:10:13